Related Experiment Video
Updated: Apr 23, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
A CREB1-TGFβ2 self-sustaining loop in glioblastoma
1Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia. Center for Cell Signaling, University of Virginia, Charlottesville, Virginia. dw2p@virginia.edu.
Abstract:
A subset of glioblastomas (GBM) has high levels of TGFβ signaling, and anti-TGFβ therapies are being pursued as treatments for GBM. The work presented here identifies CREB1 as a potential biomarker for TGFβ-dependent GBM. CREB1 integrates signaling from TGFβ and the PI3K pathway and nucleates a self-sustaining signaling loop that maintains TGFβ2 expression in GBM with high CREB1 levels.
Insights
A subset of glioblastoma (GBM) tumors show high TGFβ signaling. Researchers identified CREB1 as a potential biomarker for these TGFβ-dependent GBMs, revealing a new signaling loop.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Glioblastoma (GBM) is an aggressive brain tumor.
- A subset of GBMs exhibits elevated Transforming Growth Factor beta (TGFβ) signaling.
- Anti-TGFβ therapies are under investigation for GBM treatment.
Purpose of the Study:
- To identify potential biomarkers for TGFβ-dependent glioblastomas.
- To elucidate the role of CREB1 in TGFβ signaling pathways within GBM.
- To understand the mechanisms maintaining TGFβ expression in specific GBM subtypes.
Main Methods:
- Analysis of TGFβ signaling pathways in GBM.
- Investigating the role of CREB1 in integrating signaling pathways.
- Characterization of a self-sustaining signaling loop involving CREB1 and TGFβ2.
Main Results:
- CREB1 was identified as a potential biomarker for TGFβ-dependent GBM.
- CREB1 integrates signals from both TGFβ and Phosphatidylinositol 3-kinase (PI3K) pathways.
- A self-sustaining signaling loop, nucleated by CREB1, was found to maintain TGFβ2 expression in GBM with high CREB1 levels.
Conclusions:
- CREB1 is a key player in TGFβ-dependent GBM.
- Targeting CREB1 or the identified signaling loop may offer new therapeutic strategies for GBM.
- This finding advances the understanding of GBM heterogeneity and signaling.
Related Concept Videos
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

